Lies The Authorities Told Me

The Maddie de Garay Fraud

Senator Rebecca Rausch has once again filed a proposed law, An Act Promoting Community Immunity (AAPCI), in order to make it nearly impossible for a parent to get a medical exemption or religious exemption from any of the growing list of mandated vaccines to attend school in MA. It appears that Senator Rausch must believe that vaccines are nearly 100% safe except for “a checklist of generally accepted contraindications to immunizations that shall be completed by a provider” which one can guess involves developing anaphylaxis as she apparently relies on the “health authorities” to support this assumption. The goal of this series is to point out that the authorities appear to be dishonest with this assertion. This article will unpack what Maddie de Garay’s mother, Stephanie, revealed about Maddie’s injuries sustained in the Pfizer clinical trial for teenagers which were reported as simply “stomach pain” [1].

If Pfizer & the trial PI’s didn’t lie, people wouldn’t have debilitating illnesses like my 14yo daughter still has after dose 2 in Pfizer 12-15yo trial at Cincinnati Children’s. They hid her reaction and worse yet did not treat her! She has CIDP, SFN & POtS

CIDP is an acronym for chronic inflammatory demyelinating polyradiculoneuropathy which is a slowly developing autoimmune disorder in which the body’s immune system attacks the myelin that insulates and protects your body’s nerves in which experts think that CIDP is related to Guillain-Barre syndrome (GBS) but less common [2]. Common symptoms for those suffering from CIDP include gradual weakness or sensation changes in the arms and or legs, and paralysis which may require a respirator for breathing support. SFN is an acronym for small fiber neuropathy which only the small sensory cutaneous nerves are affected in which the majority of patients experience sensor disturbances that start with the feet and progress upwards [3]. Symptoms typically include unusual pins-and-needles, pricks, tingling, and numbness sensations; however, more severe sensations include burning pain, coldness, and even electric shock-like sensations which can be quite painful. Finally, POtS is an acronym used for postural orthostatic tachycardia syndrome. POtS is a form of dysautonomia, a disorder of the autonomic nervous system, resulting in a blood circulation disorder characterized by two factors:

• a specific group of symptoms that frequently occur when standing upright

• a heart rate increase from horizontal to standing (or as tested on a tilt table) of at least 30 beats per minute in adults, or at least 40 beats per minute in adolescents, measured during the first 10 minutes of standing [4].

The Pfizer clinical trial which Maddie participated in, involved only 1,131 children aged 12-15 who received a vaccine and were compared to 1,129 children who received a placebo. After around 8 weeks of monitoring for serious adverse events (SAEs), 5 were reported in the vaccinated group and 2 were reported in the placebo group which suggests a relative risk ratio of 2.50. In which the regulators [5] concluded:

No SAEs were judged by FDA to be related to vaccination (Table 3c). There were no cases of vaccine-associated enhanced disease or deaths. Grade ≥3, or severe, local or systemic reactions within 7 days following either vaccination, were reported by 10.7% of vaccine recipients, and occurred more frequently in the vaccine than placebo groups (Table 3d). No serious concerns impacted the certainty of the estimate of reactogenicity.

However, Maddie’s CIDP injury occurred 28 days after her second mRNA vaccination, the duration in which the peak rate of GBS injuries occurred in the vaccine safety datalink (VSD) study for those who received mRNA vaccines [6]. A study included studied by a member of the COVID-19 Vaccine Safety Technical Subgroup in the vaccine safety datalink following COVID-19 vaccination [6]. Among the studies, authors, Dr. Nelson, an ACIP/CDC member of the COVID-19 Vaccine Safety Technical Subgroup, presented an earlier version of this data which the CDC referred to in [7]. Yet, to date, the CDC will not acknowledge the risk of developing GBS following an mRNA vaccine; however, they did acknowledge the risk following the viral vector Janssen vaccine which suggests rates of GBS injury exceeding those of the 1976 Swine Flu vaccine [9].

Comparing Case Rates of Acute GBS following vaccination for mRNA to the H1N1 Flu Vaccine [8].

What are the odds that Maddie developed CIDP during this 8-week study by chance? GBS occurs in teens at a rate of roughly a third of that for adults, 4 cases per million person-years. The duration of the study was 8 weeks, so the likelihood of having a 12-15-year-old develop GBS would be one in two million chance of occurring. Therefore, there was roughly a one in 1,768 chance of this occurring in the study of 1,131 12-15-year-olds.

Yet the CDC has now added the COVID-19 vaccine to their pediatric schedule in which infants can receive up to 3 doses before they are ten months old [10] and Senator Rausch proposes to make it nearly impossible to be exempt from such a schedule of these and/or other vaccines required for your child to attend a “covered program” which includes:

(a) a child care center, an early education and care program, a family child care home, a large family child care home, a public preschool program, or a school-aged child care program, as defined in section 1A of chapter 15D; (b) a school, whether public, private or charter, that provides education to students in any combination of grade levels from kindergarten to grade 12, inclusive, and including, but not limited to, any school activity open to children who are otherwise instructed in accordance with section 1 of chapter 76; (c) a recreational camp; or (d) an institution of higher education, whether public or private [AAPCI text].

If a parent is fortunate enough to obtain an annual medical exemption for a COVID-19 booster due to their child developing GBS following a primary series of COVID-19 vaccinations as an infant it may, in the end, be rendered moot; however, should the authorities gain “consent” from their child into receiving the booster at school while bypassing federal laws since

Any minor may give consent to his medical or dental care at the time such care is sought if … (vi) he reasonably believes himself to be suffering from or to have come in contact with [be at risk of contracting] any disease defined as dangerous to the public health pursuant to section six of chapter one hundred and eleven; provided, however, that such minor may only consent to care which relates to the diagnosis [, prevention] or treatment of such disease.

Note: AAPCI deletions were indicated by a cross out and insertions are inside brackets.

Now it’s not clear to me how all these rules proposed in Senator Rebecca Rausch’s law will benefit infants’ and students’ health; however, what is clear is that it will serve as a financial benefit to both the manufacturers and regulators who continue to add these vaccinations to the CDC’s growing pediatric schedule. For example, “third-party royalties to the NIH doubled to $127 million in 2021, from the Pfizer vaccine” and NIAD received an additional $400 million from Moderna. Finally, these mandates will continue to help manufacturers such as Pfizer grow annual sales ranging from tens to hundreds of billions of dollars.

References:

1. Pfizer Has a Long History of Fraud, Corruption and Using Children as Human Guinea Pigs by CD Media Staff.

2. Chronic Inflammatory Demyelinating Polyradiculoneuropathy Johns Hopkins Medicine.

3. Small Fiber Sensory Neuropathy, Johns Hopkins Medicine.

4. Postural Orthostatic Tachycardia Syndrome (POTS), John Hopkins Medicine.

5. Grading of Recommendations, Assessment, Development, and Evaluation (GRADE): Pfizer-BioNTech COVID-19 Vaccine for Persons Aged 12-15 Year, ACIP, May 12, 2021.

6. Hanson, K.E., Goddard, K., Lewis, N., Fireman, B., Myers, T.R., Bakshi, N., Weintraub, E., Donahue, J.G., Nelson, J.C., Xu, S. and Glanz, J.M., 2022. Incidence of Guillain-Barré Syndrome After COVID-19 Vaccination in the Vaccine Safety Datalink. JAMA network open, 5(4), pp.e228879-e228879.

7. Rosenblum, H.G., Hadler, S.C., Moulia, D., Shimabukuro, T.T., Su, J.R., Tepper, N.K., Ess, K.C., Woo, E.J., Mba-Jonas, A., Alimchandani, M. and Nair, N., 2021. Use of COVID-19 vaccines after reports of adverse events among adult recipients of Janssen (Johnson & Johnson) and mRNA COVID-19 vaccines (Pfizer-BioNTech and Moderna): update from the Advisory Committee on Immunization Practices—United States, July 2021. Morbidity and Mortality Weekly Report, 70(32), p.1094. URL: https://www.cdc.gov/mmwr/volumes/70/wr/mm7032e4.htm#T1_down

8. Kottenstette, N. Iatrogenic Guillain-Barre Syndrome (GBS) case rates in the USA URL: nickkottenstette.substack.com/p/iatrogenic-guillain-barre-syndrome

9. Selected Adverse Events Reported after COVID-19 Vaccination, CDC.

10. Recommended Vaccinations for Infants and Children, Parent-Friendly Version, CDC.